Cypress Capital Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.26M Buy
2,522
+1,366
+118% +$656K 0.12% 133
2026
Q1
$568K Hold
1,156
0.06% 159
2025
Q4
$670K Sell
1,156
-1
-0.1% -$566 0.08% 146
2025
Q3
$561K Sell
1,157
-25
-2% -$11.6K 0.07% 156
2025
Q2
$479K Buy
+1,182
New +$494K 0.06% 154
2023
Q4
Sell
-724
Closed -$366K 302
2023
Q3
$366K Sell
724
-143
-16% -$76.2K 0.05% 238
2023
Q2
$452K Buy
867
+347
+67% +$187K 0.07% 226
2023
Q1
$300K Buy
520
+105
+25% +$59.2K 0.05% 248
2022
Q4
$229K Buy
+415
New +$220K 0.03% 275
2022
Q2
Sell
-691
Closed -$408K 305
2022
Q1
$408K Buy
691
+315
+84% +$181K 0.05% 233
2021
Q4
$251K Sell
376
-142
-27% -$88.7K 0.03% 280
2021
Q3
$296K Buy
518
+52
+11% +$28.5K 0.04% 243
2021
Q2
$235K Sell
466
-213
-31% -$101K 0.03% 256
2021
Q1
$310K Sell
679
-110
-14% -$52.5K 0.04% 235
2020
Q4
$368K Buy
789
+227
+40% +$106K 0.06% 224
2020
Q3
$248K Buy
+562
New +$232K 0.04% 229
2020
Q1
Sell
-620
Closed -$201K 239
2019
Q4
$201K Buy
+620
New +$188K 0.04% 236
2019
Q3
Sell
-926
Closed -$272K 250
2019
Q2
$272K Buy
926
+96
+12% +$26.4K 0.05% 206
2019
Q1
$227K Buy
+830
New +$207K 0.05% 225

Other funds holding TMO

Cypress Capital Group's TMO Position: Q2 2026 in Review

Cypress Capital Group increased its Thermo Fisher Scientific (TMO) stake by 118% in Q2 2026, buying an estimated $656K and bringing the position to 2,522 shares worth $1.26M. The position accounts for 0.12% of the portfolio, ranked #133.

Cypress Capital Group first reported a position in TMO in Q1 2019 and has held it in 19 quarters since. 2,025 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Cypress Capital Group held 2,522 shares of Thermo Fisher Scientific worth $1.26M as of Q2 2026.
  • Cypress Capital Group bought 1,366 Thermo Fisher Scientific shares in Q2 2026, an estimated $656K.
  • Thermo Fisher Scientific made up 0.12% of Cypress Capital Group's portfolio in Q2 2026, its #133 holding.
  • Cypress Capital Group first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 19 quarters since.
  • 2,025 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Cypress Capital Group's 13F filing for Q2 2026, filed 5 Aug 2026.